Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Hodgkin Disease 48Recurrence 13Lymphoma 12Lymphoma, T-Cell, Cutaneous 10Lymphoma, T-Cell, Peripheral 9Mycosis Fungoides 8Lymphoma, T-Cell 7Lymphoma, Large-Cell, Anaplastic 7Sezary Syndrome 5Lymphoma, Non-Hodgkin 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Large B-Cell, Diffuse 4Immunoblastic Lymphadenopathy 4Enteropathy-Associated T-Cell Lymphoma 4Neoplasms, Germ Cell and Embryonal 3Lymphomatoid Papulosis 3Lymphoma, Follicular 3Leukemia, Myeloid, Acute 3Leukemia 3Testicular Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms 2Lymphoma, Primary Cutaneous Anaplastic Large Cell 2Lymphoma, Extranodal NK-T-Cell 2Lymphoma, B-Cell, Marginal Zone 2Lymphatic Diseases 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia, Large Granular Lymphocytic 2Hematologic Neoplasms 2Carcinoma, Embryonal 2

Interventions

Paclitaxel 5Ifosfamide 5Filgrastim 3Etoposide 3Cisplatin 3Therapeutics 2Carboplatin 2Brentuximab Vedotin 2pegfilgrastim 1liposomal amphotericin B 1Vinblastine 1Thiotepa 1Sunitinib 1Ribavirin 1Radiotherapy 1Psychiatric Rehabilitation 1Peripheral Blood Stem Cell Transplantation 1Palivizumab 1Oxaliplatin 1Mesna 1Itraconazole 1Interleukin-12 Subunit p35 1Interleukin-11 1Granulocyte Colony-Stimulating Factor 1Fluconazole 1Cyclophosphamide 1Caspofungin 1Captopril 1Bleomycin 1Beclomethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Embryonal × Brentuximab Vedotin × Clear all
NCT02689219 2019-12-10

Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors

Indiana University

Phase 2 Terminated
18 enrolled 13 charts
Genitourinary

Nonseminomatous germ cell tumor, Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms, Carcinoma, Embryonal

NCT01851200 2018-02-07

Brentuximab Vedotin (SGN-35) as Salvage Treatment for CD30-positive Germ Cell Tumors

Fondazione Michelangelo

Phase 2 Completed
9 enrolled
Genitourinary

Neoplasm Metastasis, Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms, Carcinoma, Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡